Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Protalix BioTherapeutics Inc.    PLX

Delayed Quote. Delayed  - 06/24 10:02:15 pm
0.685 USD   -5.65%
06/06 Protalix BioTherapeutics Initiates PRX-102 Global Phase III Clini..
06/02 Protalix BioTherapeutics to Present at the Jefferies 2016 Global ..
05/09 PROTALIX BIOTHE : reports 1Q loss
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse Mkt
06/20/2016 06/21/2016 06/22/2016 06/23/2016 06/24/2016 Date
0.769(c) 0.76(c) 0.7217(c) 0.726(c) 0.685(c) Last
49 992 60 298 32 334 51 320 75 726 Volume
+2.53% -1.17% -5.04% +0.60% -5.65% Change
More quotes
Financials ($)
Sales 2013 15,8 M
EBIT 2013 -19,9 M
Net income 2013 -19,0 M
Debt 2013 -
Yield 2013 -
Sales 2014 35,8 M
EBIT 2014 -12,9 M
Net income 2014 -4,70 M
Debt 2014 -
Yield 2014 -
P/E ratio 2013 -
P/E ratio 2014
Capi. / Sales2013 4,34x
Capi. / Sales2014 1,91x
Capitalization 68,4 M
More Financials
Company
Protalix Biotherapeutics, Inc. engages in the development and commercialization of recombinant therapeutic proteins based on ProCellEx plant cell based expression system.It offers Taliglucerase alfa injections under the brand name Elelyso, an enzyme replacement therapy for Gaucher disease.Its drug... 
More about the company
Surperformance© ratings of Protalix BioTherapeutics I
Trading Rating : Investor Rating :
More Ratings
Latest news on PROTALIX BIOTHERAPEUTICS I
06/07 PROTALIX BIOTHERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements ..
06/06 PROTALIX BIOTHERAPEUTICS, INC. : Other Events (form 8-K)
06/06 Protalix BioTherapeutics Initiates PRX-102 Global Phase III Clinical Trial of..
06/02 Protalix BioTherapeutics to Present at the Jefferies 2016 Global Healthcare C..
05/09 PROTALIX BIOTHERAPEUTICS : reports 1Q loss
05/09 PROTALIX BIOTHERAPEUTICS, INC. : Results of Operations and Financial Condition (..
05/09 Protalix BioTherapeutics Reports First Quarter 2016 Financial Results and Pro..
04/08 PROTALIX BIOTHERAPEUTICS : Other Events (form 8-K)
04/01 PROTALIX BIOTHERAPEUTICS : Amendments to Articles of Inc. or Bylaws; Change in F..
03/08 PROTALIX BIOTHERAPEUTICS : Results of Operations and Financial Condition (form 8..
More news
Sector news : Biotechnology & Medical Research - NEC
06/25 NOVARTIS : SC requests solicitor general to consider on biosimilars
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
06/24 MEDIVATION : Glass Lewis Recommends Medivation's Stockholders Support the Compan..
06/24 MEDIVATION : Glass Lewis Recommends Medivation’s Stockholders Support the ..
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart PROTALIX BIOTHERAPEUTICS I
Duration : Period :
Protalix BioTherapeutics I Technical Analysis Chart | PLX | US74365A1016 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions